Sequoia Financial Advisors LLC Buys 597 Shares of iShares Biotechnology ETF (NASDAQ:IBB)

Sequoia Financial Advisors LLC increased its stake in shares of iShares Biotechnology ETF (NASDAQ:IBB) by 22.9% in the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 3,205 shares of the financial services provider’s stock after buying an additional 597 shares during the quarter. Sequoia Financial Advisors LLC’s holdings in iShares Biotechnology ETF were worth $424,000 at the end of the most recent quarter.

A number of other institutional investors and hedge funds have also bought and sold shares of the stock. Darwin Wealth Management LLC purchased a new position in iShares Biotechnology ETF during the 3rd quarter worth $29,000. HHM Wealth Advisors LLC lifted its position in shares of iShares Biotechnology ETF by 200.0% during the fourth quarter. HHM Wealth Advisors LLC now owns 225 shares of the financial services provider’s stock valued at $30,000 after purchasing an additional 150 shares in the last quarter. Bradley & Co. Private Wealth Management LLC purchased a new position in iShares Biotechnology ETF during the fourth quarter worth about $32,000. Newbridge Financial Services Group Inc. bought a new stake in iShares Biotechnology ETF in the 4th quarter worth about $33,000. Finally, Hager Investment Management Services LLC purchased a new stake in iShares Biotechnology ETF in the 4th quarter valued at about $34,000. 62.45% of the stock is owned by hedge funds and other institutional investors.

iShares Biotechnology ETF Stock Down 1.5 %

Shares of NASDAQ IBB opened at $134.09 on Wednesday. The company has a market capitalization of $6.11 billion, a PE ratio of 27.83 and a beta of 0.77. The stock’s 50 day moving average price is $136.26 and its 200-day moving average price is $139.57. iShares Biotechnology ETF has a twelve month low of $123.60 and a twelve month high of $150.57.

iShares Biotechnology ETF Increases Dividend

The firm also recently disclosed a dividend, which will be paid on Friday, March 21st. Shareholders of record on Tuesday, March 18th will be given a $0.1212 dividend. The ex-dividend date is Tuesday, March 18th. This is a boost from iShares Biotechnology ETF’s previous dividend of $0.06.

About iShares Biotechnology ETF

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.